The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Natera, Inc. Common Stock 632307104 18,154 1,550,280 SH   SOLE   1,550,280 0 0
Mirna Therapeutics, Inc. Common Stock 60470J103 5,355 2,974,812 SH   SOLE   2,974,812 0 0
Versartis, Inc. Common Stock 92529L102 35,193 2,361,978 SH   SOLE   2,361,978 0 0
Innocoll Holdings PLC Ordinary Shares G4783X105 1,451 2,103,173 SH   SOLE   2,103,173 0 0
Aclaris Therapeutics, Inc. Common Stock 00461U105 62,136 2,289,480 SH   SOLE   2,289,480 0 0
Auris Medical Holding AG Common Shares H03579101 6,225 5,818,175 SH   SOLE   5,818,175 0 0
Histogenics Corporation Common Stock 43358V109 3,469 2,077,040 SH   SOLE   2,077,040 0 0
Sophiris Bio Inc. Common Stock 83578Q209 560 200,000 SH   SOLE   200,000 0 0
Spark Therapeutics, Inc. Common Stock 84652J103 45,159 904,986 SH   SOLE   904,986 0 0